Viewing StudyNCT00258687



Ignite Creation Date: 2024-05-05 @ 12:09 PM
Last Modification Date: 2024-10-26 @ 9:21 AM
Study NCT ID: NCT00258687
Status: COMPLETED
Last Update Posted: 2021-03-03
First Post: 2005-11-23

Brief Title: Vaccine Trial for Clear Cell Sarcoma Pediatric Renal Cell Carcinoma Alveolar Soft Part Sarcoma and Children With Stage IV Melanoma
Sponsor:
Organization: Dana-Farber Cancer Institute

Study Design

Study Type: INTERVENTIONAL
Expanded Access Type Individual: None
Expanded Access Type Intermediate: None
Expanded Access Type Treatment: None
Patient Registry: None
Target Duration: None
Design Allocation:
Design Intervention Model:
Design Intervention Model Description:
Design Masking Description:
Bio Spec Retention: None
Bio Spec Description: None
Enrollment Count: 12
Enrollment Type: ACTUAL
Design Primary Purpose:
Design Masking:
Phases:
Name
PHASE1
Observational Models:
Time Perspective List:
Who Masked List: